-
CIED Complication Rates Vary Considerably Among Hospitals
drugs
July 31, 2019
Cardiovascular implantable electronic device (CIED) complication rates vary considerably among hospitals...
-
CV Event Risk Up With Rejected, Abandoned PCSK9i Prescriptions
drugs
July 30, 2019
Patients with rejected or abandoned prescriptions for proprotein convertase subtilisin kexin type 9 inhibitors (PCSK9i) have a significantly increased risk...
-
Testosterone Replacement Therapy May Increase Cardiovascular Risk
drugs
July 29, 2019
For aging men with low testosterone levels, testosterone replacement therapy (TRT) may increase the risk of cardiovascular events...
-
AHA News: Early Pregnancy May Be a Prime Time to Promote Heart Health
drugs
July 24, 2019
Improving cardiovascular health during the early stages of pregnancy can lead not only to a healthier pregnancy...
-
People Living With HIV Have Higher Risk for Cardiovascular Disease
drugs
July 19, 2019
People living with HIV (PLWH) have a higher risk for cardiovascular disease, according to a study published online in the Journal of the American Heart Association.
-
Three Interventions Could Cut Cardiovascular Deaths
drugs
June 28, 2019
Three Interventions Could Cut Cardiovascular Deaths.
-
Job cuts limit cardiovascular and diabetes research and development
europeanpharmaceuticalreview
June 26, 2019
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
-
Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®
worldpharmanews
June 20, 2019
Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®.
-
ADA: Dulaglutide Tied to Decline in Cardiovascular Events in T2DM
drugs
June 12, 2019
Dulaglutide Tied to Decline in Cardiovascular Events in T2DM.
-
Untreated White Coat HTN May Increase Cardiovascular Risk
drugs
June 11, 2019
Untreated White Coat HTN May Increase Cardiovascular Risk.